1-4 of 4
Heidi Nyman
Close
Sort by
Journal Articles

High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Dose-Dense Chemoimmunotherapy and Systemic CNS Prophylaxis. Results From a Nordic Phase II Study

Sari Riihijarvi, Heidi Nyman, Harald Holte, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Eriksson Mikael, Sirpa Leppa
Journal: Blood
Blood (2010) 116 (21): 4142.
https://doi.org/10.1182/blood.V116.21.4142.4142
Published: 2010
Journal Articles

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy

Heidi Nyman, Magdalena Adde, Marja-Liisa Karjalainen-Lindsberg, Minna Taskinen, Mattias Berglund, Rose-Marie Amini, Carl Blomqvist, Gunilla Enblad, Sirpa Leppä
Journal: Blood
Blood (2007) 109 (11): 4930–4935.
https://doi.org/10.1182/blood-2006-09-047068
Published: 2007
Includes: Supplemental data
Journal Articles

Cost-Effectiveness of Rituximab Maintenance Treatment Versus Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed Follicular Lymphoma (FL).

Sirpa Leppä, MD, PhD, Miika Linna, PhD, Heidi Nyman, MD, Eeva Taimela, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3337.
https://doi.org/10.1182/blood.V108.11.3337.3337
Published: 2006
Journal Articles

Does Rituximab Influence the Prognostic Effect of Germinal Centre Phenotype in Diffuse Large B-Cell Lymphoma?.

Heidi Nyman, MD, Marja-Liisa Karjalainen-Lindsberg, MD, Minna Taskinen, M.Sci, Mattias Berglund, M.Sci, Magdalena Adde, MD, Rose-Marie Amini, MD, Carl Blomqvist, MD, Gunilla Enblad, MD, Sirpa Leppä, MD
Journal: Blood
Blood (2006) 108 (11): 2743.
https://doi.org/10.1182/blood.V108.11.2743.2743
Published: 2006